These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7014931)

  • 41. Bacillus Calmette-Guerin and interleukin-2 for treatment of superficial bladder cancer.
    Cockett AT; Davis RS; Cos LR; Wheeless LL
    J Urol; 1991 Sep; 146(3):766-9; discussion 769-70. PubMed ID: 1875490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors.
    Kavoussi LR; Torrence RJ; Gillen DP; Hudson MA; Haaff EO; Dresner SM; Ratliff TL; Catalona WJ
    J Urol; 1988 May; 139(5):935-40. PubMed ID: 3361667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Granulomatous prostatitis following bacillus Calmette-Guerin immunotherapy of bladder cancer.
    Oates RD; Stilmant MM; Freedlund MC; Siroky MB
    J Urol; 1988 Oct; 140(4):751-4. PubMed ID: 3418796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tuberculous iliac lymphadenitis: a rare complication of intravesical bacillus Calmette-Guerin and cause of tumor over staging.
    Ali-el Dein B; Nabeeh A
    J Urol; 1996 Nov; 156(5):1766-7. PubMed ID: 8863597
    [No Abstract]   [Full Text] [Related]  

  • 45. Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor.
    Coplen DE; Marcus MD; Myers JA; Ratliff TL; Catalona WJ
    J Urol; 1990 Sep; 144(3):652-7. PubMed ID: 2388321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bladder cancer immunotherapy.
    Lamm DL; Thor DE; Stogdill VD; Radwin HM
    J Urol; 1982 Nov; 128(5):931-5. PubMed ID: 6757467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Are cystoscopy and urinary cytology sufficient to identify candidates for subsequent biopsy after bacillus Calmette-Guérin treatment in patients with bladder carcinoma in situ?
    Haase RN; Harving N
    Scand J Urol; 2015; 49(4):338-40. PubMed ID: 25660358
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.
    Herr HW; Pinsky CM; Whitmore WF; Sogani PC; Oettgen HF; Melamed MR
    J Urol; 1986 Feb; 135(2):265-7. PubMed ID: 3511284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Dose-Response Relationship of bacillus Calmette-Guérin and Urothelial Carcinoma Cell Biology.
    Shah G; Zhang G; Chen F; Cao Y; Kalyanaraman B; See WA
    J Urol; 2016 Jun; 195(6):1903-10. PubMed ID: 26694905
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results.
    Pansadoro V; Emiliozzi P; Defidio L; Donadio D; Florio A; Maurelli S; Lauretti S; Sternberg CN
    J Urol; 1995 Dec; 154(6):2054-8. PubMed ID: 7500457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
    Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M
    J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Miliary tuberculosis secondary to transurethral bacillus Calmette-Guérin administration for superficial transitional cell carcinoma of the bladder.
    Skoutelis A; Melekos MD; Bassaris HJ
    J Natl Cancer Inst; 1990 Jul; 82(14):1219-20. PubMed ID: 2362292
    [No Abstract]   [Full Text] [Related]  

  • 53. Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology.
    Badalament RA; Gay H; Cibas ES; Herr HW; Whitmore WF; Fair WR; Melamed MR
    J Urol; 1987 Oct; 138(4):763-5. PubMed ID: 3656528
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An analysis of the effect of statin use on the efficacy of bacillus calmette-guerin treatment for transitional cell carcinoma of the bladder.
    Berglund RK; Savage CJ; Vora KC; Kurta JM; Cronin AM
    J Urol; 2008 Oct; 180(4):1297-300; discussion 1300. PubMed ID: 18707737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistent acid-fast bacilli following intravesical bacillus Calmette-Guerin.
    Linn R; Klimberg IW; Wajsman Z
    J Urol; 1989 May; 141(5):1197-8. PubMed ID: 2709508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Symptomatic granulomatous prostatitis following bacillus Calmette-Guerin immunotherapy for bladder cancer.
    Noor MA; Biyabani SR; Burney IA; Talatia J
    J Pak Med Assoc; 2002 Dec; 52(12):578-80. PubMed ID: 12627909
    [No Abstract]   [Full Text] [Related]  

  • 57. Granulomatous hepatitis following intravesical bacillus Calmette-Guerin therapy for bladder carcinoma.
    Marans HY; Bekirov HM
    J Urol; 1987 Jan; 137(1):111-2. PubMed ID: 3795348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Re: Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.
    Herr HW
    J Urol; 1987 Aug; 138(2):409-10. PubMed ID: 3599266
    [No Abstract]   [Full Text] [Related]  

  • 59. Purulent abscess after bacillus Calmette-Guerin therapy for bladder cancer.
    Konrad K; Földes K
    J Rheumatol; 1995 Jul; 22(7):1441. PubMed ID: 7562797
    [No Abstract]   [Full Text] [Related]  

  • 60. Ruptured mycotic abdominal aortic aneurysm secondary to Mycobacterium bovis after intravesical treatment with bacillus Calmette-Guérin.
    Harding GE; Lawlor DK
    J Vasc Surg; 2007 Jul; 46(1):131-4. PubMed ID: 17606130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.